
Galapagos plans to end cell therapy efforts and close sites
Galapagos has announced its intention to wind down its cell therapy business, following a comprehensive review of strategic alternatives, including a potential divestiture. The move follows similar ones by Novo Nordisk and Takeda, which recently announced the decision to discontinue its cell therapy efforts, as part of a “strategic portfolio… Read More


